Activity Provided By:

The France Foundation

Importance of Early Diagnosis and Screening in SMA

Overview / Abstract:	This activity discusses new, emerging, and targeted treatments for SMA. The activity also explores the potential clinical challenges and how this affects phenotypes over time.
Expiration	Sep 30, 2021
Discipline(s)	Physician CME
Format	Webinar / Webcast / Video
Credits / Hours	0.25
Accreditation	ACCME
Presenters / Authors / Faculty	Sharon Aharoni, MD Director of SMA Therapies, Schneider Institute of Child Neurology Children’s Medical Center Petach Tikva, Israel Professor Enrico Bertini Unit of Neuromuscular and Neurodegenerative Disorders Laboratory of Molecular Medicine Bambino Gesu' Children's Research Hospital Rome, Italy Professor Aviva Fattal-Valevski Director, Pediatric Neurology Institute Dana Children's Hospital, Tel Aviv Medical Center Tel Aviv, Israel Professor Marcondes Cavalcante França Junior Assistant Professor of Neurology The University of Campinas Sao Paulo, Brazil Professor Wolfgang Mueller-Felber Head of Center for Pediatric Neuromuscular Disorders and Clinical Neurophysiology Dr. von Hauner Children’s Hospital Munich, Germany J. Andoni Urtizberea, MD, MSc Attending Physician Institut de Myologie Paris, France
Sponsors / Supporters / Grant Providers	This activity is supported by an educational grant from AveXis.
Keywords / Search Terms	The France Foundation The France Foundation SMA, gene therapy Free CE CME Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map